Ilsung IS

003120 · KOSPI · Health Care · SMALL CAP

Revenue down 6.85% in FY2025.

Ilsung IS reported separate results for FY2025: revenue of US$44.3M (−6.85% year on year), an operating loss of US$4.24M and net income of US$935K (−89.63% year on year).

Earnings(Change of 30% or more in revenue or profit/loss structure (15% for large companies))· FILED 2026-02-03· RCEPT 20260203800761

US$44.3MRevenue
−6.85%Revenue vs a year earlier
−US$4.24MOperating profit

Converted at 1 USD ≈ ₩1,452.54 (filing-date rate, 2026-02-03 close)

What happened

Ilsung IS reported separate results for FY2025: revenue of US$44.3M (−6.85% year on year), an operating loss of US$4.24M and net income of US$935K (−89.63% year on year).

Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.

RevenueUS$44.3M
Revenue vs a year earlier−6.85%
Operating profit−US$4.24M
Net incomeUS$935K
PeriodFY2025 (separate)
Filed2026-02-03, Change of 30% or more in revenue or profit/loss structure (15% for large companies)
SourceDART rcept 20260203800761 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-03 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.